Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
13
Number of overlapping holdings
43.3%
% of MEDX's 30 holdings also in FTXH
26.0%
% of FTXH's 51 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 8.2% | 6.9% | 6.9% | |
BRISTOL-MYERS SQUIBB CO | 6.1% | 8.7% | 6.1% | |
JOHNSON & JOHNSON | 4.6% | 6.9% | 4.6% | |
MERCK & CO. INC. | 4.2% | 6.7% | 4.2% | |
PFIZER INC | 4.1% | 6.8% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to FTXH
ELI LILLY & CO | 13.2% | |
NOVARTIS AG-ADR | 5.8% | |
ASTRAZENECA PLC-SPONS ADR | 5.1% | |
ALNYLAM PHARMACEUTICALS INC | 3.7% | |
ALKERMES PLC | 3.2% | |
CRISPR THERAPEUTICS AG | 2.9% | |
AMGEN INC | 2.5% | |
IONIS PHARMACEUTICALS, INC. | 2.4% | |
GLAXOSMITHKLINE PLC-SPON ADR | 2.4% | |
BEAM THERAPEUTICS, INC. | 1.7% |
MEDX Underweight Relative to FTXH
GILEAD SCIENCES INC | -4.5% | |
CARDINAL HEALTH INC | -4.1% | |
VIATRIS, INC. | -3.8% | |
ZOETIS INC | -3.8% | |
UNITED THERAPEUTICS CORP | -3.7% | |
JAZZ PHARMACEUTICALS PLC | -3.5% | |
PFIZER INC | -2.8% | |
BRISTOL-MYERS SQUIBB CO | -2.6% | |
ORGANON & CO. | -2.5% | |
MERCK & CO. INC. | -2.5% |